what is considered glp 1 microdose GLP-1 microdosing popular, but there's little evidence it works Microdosing Ozempic for Psoriatic Arthritis:

J Endocr Soc 5(9):bvab118 Doggrell SA (2023) Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist, a step forward in the treatment of diabetes and obesity

Alternatives to Peptide and GLP-1 Therapies Lifestyle Approaches: Nutrition, exercise, and behavioral therapies remain cornerstone solutions

It could harm the fetus or newborn

Description Retatrutide Peptide Product Description Retatrutide peptide (LY3437943) is an investigational synthetic peptide designed to activate three key metabolic hormone receptors simultaneously: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCG)

Your medical provider will determine the appropriate patch strength for you based on your medical history and treatment goals, which may differ from an injection dosage

With a molecular weight of approximately 4731 g/mol and a molecular formula of C221H342N46O68 (though some sources note C223H343F3N46O70 due to trifluoroacetate salt variations), Retatrutides structure supports its role as a triple agonist targeting glucagon (GCGR), glucose-dependent insulinotropic polypeptide (GIPR), and glucagon-like peptide-1 (GLP-1R) receptors